Solistaa Pharmaceuticals Private Limited - Company Profile

It is a food and beverages private limited company based in Pondicherry, Pondicherry, India, established in 2017.
2017 Pondicherry, Pondicherry, India Active
Last Updated:
Access Report
About Solistaa Pharmaceuticals Private Limited

Solistaa Pharmaceuticals Private Limited, a active private limited company, was established on 27 November 2017 in Pondicherry, Pondicherry, India. Engaging in organic & health foods within the manufacturing sector, it holds CIN: U24304PY2017PTC008222. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹4.15 Cr.

It upholds a compliant status. Employing 118 professional, Its leadership includes Paramasivan Sivarajakumar (Director), Kandoth Kunnumpreth Vinupal (Director), Sundararajalu (Director). Past directors included Mangalaraj Kirubakaran Daniel, Konetampet Gopalakrishnan. It holds ₹31.56 Cr open charges and ₹33.75 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.37, 1St Cross, Perumal Raja Garden Reddiarpalayam, Pondicherry, Pondicherry, 605010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304PY2017PTC008222

  • Registration Number

    008222

  • Incorporation Date

    27 November 2017

  • Authorized Capital

    ₹4.50 Cr

  • Paid-Up Capital

    ₹4.15 Cr

  • ROC Code

    Roc Pondicherry

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 4.50 Cr
  • Paid Up Capital ₹ 4.15 Cr
  • Company Age 8 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 31.56 Cr
  • Satisfied Charges ₹ 33.75 Cr
  • Revenue Growth **** -12.24%
  • Profit Growth **** -42.76%
  • Ebitda **** -8.86%
  • Net Worth 24.10%
  • Total Assets **** 7.90%
Company report

Solistaa Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Solistaa Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Solistaa Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Paramasivan Sivarajakumar Director 27 Nov 2017 Current
Kandoth Kunnumpreth Vinupal Director 27 Nov 2017 Current
Sundararajalu Director 30 Jan 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Mar 2022 Past
Pramod Abcsdd Director 13 Mar 2018 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Solistaa Pharmaceuticals.

Solistaa Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 12.24% decrease. The company also saw a substantial fall in profitability, with a 42.76% decrease in profit. The company's net worth Soared by an impressive increase of 24.1%.

Solistaa Pharmaceuticals revenue growth over time
Solistaa Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -12.24%
*******
*******
*******
*******
Revenue from Operations
*******
 -12.25%
*******
*******
*******
*******
Total Assets
*******
 7.90%
*******
*******
*******
*******
Profit or Loss
*******
 -42.76%
*******
*******
*******
*******
Net Worth
*******
 24.10%
*******
*******
*******
*******
EBITDA
*******
 -8.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Solistaa Pharmaceuticals?

In 2024, Solistaa Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹315,625,000.00

Satisfied Charges

₹337,500,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 18.75 Cr
  • Sidbi : 12.81 Cr
Latest Charge Details
Date Lender Amount Status
13 Nov 2024 Sidbi ₹2.60 Cr Open
15 Apr 2024 State Bank Of India ₹18.75 Cr Open
26 Mar 2024 Sidbi ₹1.65 Cr Open
21 Jul 2023 Sidbi ₹1.20 Cr Open
30 Aug 2022 Sidbi ₹1.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Solistaa Pharmaceuticals?

Solistaa Pharmaceuticals has a workforce of 118 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Solistaa Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solistaa Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Solistaa Pharmaceuticals
Recent Activity within the Organization
  • Charges

    A charge with Sidbi amounted to Rs. 2.60 Cr with Charge ID 100999168 was registered on 13 Nov 2024. was recorded as a recent event.

  • Annual General Meeting

    Progress on Solistaa Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    Progress on A charge registered on 20 Mar 2020 via Charge ID 100331721 with Sidbi was fully satisfied on 07 Jun 2024. was documented.

  • Charges

    Progress on A charge registered on 02 Dec 2022 via Charge ID 100668721 with Others was fully satisfied on 27 May 2024. was documented.

  • Charges

    Progress on A charge registered on 30 Nov 2022 via Charge ID 100668650 with Others was fully satisfied on 27 May 2024. was documented.

  • Charges

    A charge registered on 19 Nov 2022 via Charge ID 100669046 with Others was fully satisfied on 27 May 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Solistaa Pharmaceuticals Private Limited?

The CIN of Solistaa Pharmaceuticals Private Limited is U24304PY2017PTC008222.

Where is Solistaa Pharmaceuticals Private Limited headquartered?

Solistaa Pharmaceuticals Private Limited is headquartered at No.37, 1St Cross, Perumal Raja Garden Reddiarpalayam, Pondicherry, Pondicherry, 605010.

When was Solistaa Pharmaceuticals Private Limited incorporated?

Solistaa Pharmaceuticals Private Limited was incorporated on 27 November 2017.

Who are the current directors of Solistaa Pharmaceuticals Private Limited?

The current directors of Solistaa Pharmaceuticals Private Limited are

What is the primary industry of Solistaa Pharmaceuticals Private Limited?

The primary industry of Solistaa Pharmaceuticals Private Limited is Manufacturing.

Is Solistaa Pharmaceuticals Private Limited a listed company?

Solistaa Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Solistaa Pharmaceuticals Private Limited?

The authorized capital of Solistaa Pharmaceuticals Private Limited is ₹4.50 Cr, and the paid-up capital is ₹4.15 Cr.

What is the compliance status of Solistaa Pharmaceuticals Private Limited?

The compliance status of Solistaa Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available